SANGUINE CORP
10QSB, EX-27, 2000-11-28
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: SANGUINE CORP, 10QSB, 2000-11-28
Next: WADDELL & REED ADVISORS ASSET STRATEGY FD INC, N-30D, 2000-11-28



<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0000926287
<NAME> SANGUINE CORPORATION

<S>                                        <C>
<PERIOD-TYPE>                              9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          660374
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                660374
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  660374
<CURRENT-LIABILITIES>                          1092489
<BONDS>                                              0
                                0
                                          0
<COMMON>                                         27881
<OTHER-SE>                                     (459996)
<TOTAL-LIABILITY-AND-EQUITY>                    660374
<SALES>                                           7625
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                561948
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               31809
<INCOME-PRETAX>                                (586132)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (586132)
<EPS-BASIC>                                    (0.02)
<EPS-DILUTED>                                    (0.02)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission